Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Editorial, Mol Med Ther Vol: 1 Issue: 1
Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research
| Aamir Shahzad1, Randall J Cohrs2, Adong Shen3 and Cornelia Lass-Flörl4* | |
| 1Department of Structural Biology, University of Vienna, Vienna, Austria | |
| 2Department of Neurology, University of Colorado, Anschutz Medical Campus, Aurora, USA | |
| 3Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, Beijing, China | |
| 4Division of Hygiene and Medical Microbiology, Department of Hygiene, Microbiology and Social Medicine, Innsbruck, Austria | |
| Corresponding author : Dr. Cornelia Lass-Flörl Division of Hygiene and Medical Microbiology, Department of Hygiene, Microbiology and Social Medicine, Innsbruck, Austria E-mail: Cornelia.lass-floerl@i-med.ac.at |
|
| Received: July 09, 2012 Accepted: July 11, 2012 Published: July 19, 2012 | |
| Citation: Shahzad A, Cohrs RJ, Shen A, Lass-Flörl C (2012) Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research. Mol Med Ther 1:1 doi:10.4172/2324-8769.1000e101 |
Abstract
Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research
The burden of invasive fungal disease (IFD) continues to increase as a result of improved medical intervention and supportive care. The growing number of patients with a variety of risk factors (e.g. transplantation, chemotherapy, HIV infection, use of corticosteroids or new immunosuppressive agents) have caused an increase in incidence of invasive infections in recent years. Millions of individuals worldwide are affected or at risk and mortality is high.